NCT05331170View on ClinicalTrials.gov

Viral Mucosal Reprogramming

PHASE2RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 27, 2023

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions
AsthmaAllergic RhinitisCat AllergyHealthy
Interventions
BIOLOGICAL

Research Grade RG-RV

Exploration of the effects of RV inoculation on human airway mucosal programming in vivo

Trial Locations (1)

77555

RECRUITING

University of Texas Medical Branch, Galveston

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

The University of Texas Medical Branch, Galveston

OTHER